Psychedelic Medicine Is Coming. The Law Isn’t Ready
A surprising resurgence of psychedelic research has produced its first FDA-approved treatment, with more likely on the way

In March, the Food and Drug Administration approved esketamine, a drug that produces psychedelic effects, to treat depression—the first psychedelic ever to clear that bar. Meanwhile the FDA has granted "breakthrough therapy" status—a designation that enables fast-tracked research—to study MDMA (also called "ecstasy") as a treatment for post-traumatic stress disorder and psilocybin as a treatment for major depression.

#medicine #drugs #psychedelics